What is Kilpest India share price and what are the returns for Kilpest India share?

Kilpest India share price is Rs 1,173.80 as on 29 Jun, 2026, 03:46 PM IST. Kilpest India share price is up by 1.22% based on previous share price of Rs. 1170.5.

What has been highest price of Kilpest India share in last 52 weeks?

52 Week high of Kilpest India share is Rs 1,441.50 while 52 week low is Rs 1,085.00

What is the market cap of Kilpest India?

Market Capitalization of Kilpest India stock is Rs 1,007.43 Cr.

What is the PE & PB ratio of Kilpest India?

The PE ratio of Kilpest India stands at 16.99, while the PB ratio is 3.0.

Kilpest India - 3B BlackBio Dx Share Price

1,173.8014.10 (1.22%)

Closed
As On: 29 Jun, 2026, 03:46 PM IST
As On: 29 Jun, 2026, 03:56 PM IST

Sector: Pesticides/Agro...
Industry: Pesticides/Agro Ch...

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,159.70
High	1,199.70
Low	1,159.70
Prev Close	1,159.70
Volume	2,380
VWAP(₹)	1,177.64

Share Price	Value
Today/Current/Last	1,173.801,170.00
Previous Day	1,159.701,162.10

Kilpest India Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

These 38 stocks will trade ex-dividend from tomorrow. Do you own any?
News
MCX, Rites among over 200 stocks to remain in focus next week for dividend, bonus, split. Do you own any?
News
Fundamental Radar: Why is Kilpest India poised to test Rs 1,184 in 12 months? Sandeep Raina explains
News
Closure of Trading Window
Announcements

View all Kilpest India Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	45.58	55.93	39.41	26.55	27.44
Total Income Growth (%)	-18.51	41.94	48.42	-3.23	-3.41
Total Expenses	30.83	29.01	19.75	10.68	14.86
Total Expenses Growth (%)	6.29	46.85	85.00	-28.13	40.34
EBIT	14.75	26.93	19.66	15.87	12.58
EBIT Growth (%)	-45.22	36.99	23.82	26.16	-29.39
Profit after Tax (PAT)	9.56	21.73	14.71	12.59	8.40
PAT Growth (%)	-56.03	47.70	16.86	49.91	-37.34
EBIT Margin (%)	32.36	48.14	49.88	59.79	45.86
Net Profit Margin (%)	20.96	38.85	37.33	47.42	30.61
Basic EPS (₹)	11.44	26.19	17.55	14.76	9.38

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	25.93	29.01	31.82	24.67	27.93
Total Income Growth (%)	-10.60	-8.85	28.99	-11.66	5.62
Total Expenses	13.64	10.13	12.29	8.98	13.75
Total Expenses Growth (%)	34.65	-17.56	36.79	-34.68	58.36
EBIT	12.29	18.88	19.54	15.69	14.17
EBIT Growth (%)	-34.88	-3.37	24.53	10.68	-20.17
Profit after Tax (PAT)	7.45	14.46	14.94	12.46	9.24
PAT Growth (%)	-48.50	-3.22	19.91	34.80	-31.26
EBIT Margin (%)	47.40	65.08	61.38	63.59	50.75
Net Profit Margin (%)	28.71	49.85	46.95	50.51	33.10
Basic EPS (₹)	8.69	16.88	17.44	14.54	10.79

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	167.48	111.55	86.66	69.06	87.55
Total Revenue Growth (%)	50.13	28.73	25.48	-21.12	-61.87
Total Expenses	90.51	47.55	42.33	33.75	44.33
Total Expenses Growth (%)	90.32	12.35	25.40	-23.85	-42.88
Profit after Tax (PAT)	58.59	47.69	32.10	25.94	32.20
PAT Growth (%)	22.84	48.56	23.77	-19.45	-71.72
Operating Profit Margin (%)	54.40	66.45	59.97	57.42	53.72
Net Profit Margin (%)	41.28	49.43	43.30	41.94	39.92
Basic EPS (₹)	69.94	55.57	37.40	34.55	43.40

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	111.44	105.56	83.04	16.08	25.62
Total Revenue Growth (%)	5.57	27.11	416.29	-37.21	41.67
Total Expenses	45.08	41.63	36.60	13.43	17.15
Total Expenses Growth (%)	8.29	13.74	172.42	-21.68	7.23
Profit after Tax (PAT)	49.32	47.56	34.21	2.16	8.01
PAT Growth (%)	3.70	39.01	1,484.18	-73.03	366.03
Operating Profit Margin (%)	68.26	70.72	65.83	23.74	55.20
Net Profit Margin (%)	50.69	52.53	48.37	18.00	51.58
Basic EPS (₹)	57.56	55.41	39.86	2.88	10.69

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 18.51%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 50.13% outperformed its 3 year CAGR of 33.95%. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	378.00	295.72	248.10	214.06	192.09
Total Assets Growth (%)	27.82	19.19	15.91	11.44	-0.74
Total Liabilities	46.36	24.71	22.63	18.15	20.02
Total Liabilities Growth (%)	87.58	9.20	24.70	-9.33	-55.77
Total Equity	331.64	271.00	225.47	195.91	172.08
Total Equity Growth (%)	22.37	20.19	15.09	13.85	16.05
Current Ratio (x)	5.27	7.11	7.04	8.05	4.82
Total Debt to Equity (x)	0.01	0.00	0.00	0.01	0.02
Contingent Liabilities	0.00	0.20	0.19	0.19	4.74

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	350.37	297.12	249.82	29.86	31.60
Total Assets Growth (%)	17.92	18.93	736.64	-5.51	9.38
Total Liabilities	31.36	24.33	22.04	5.64	7.67
Total Liabilities Growth (%)	28.89	10.39	290.78	-26.47	23.11
Total Equity	319.02	272.79	227.78	24.22	23.93
Total Equity Growth (%)	16.95	19.76	840.46	1.21	5.65
Current Ratio (x)	6.18	6.81	6.79	5.97	4.12
Total Debt to Equity (x)	0.00	0.00	0.00	0.08	0.11
Contingent Liabilities	0.00	0.20	0.19	544.31	4.66

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	52.48	43.36	26.95	22.90	37.33
Net Cash used in Investing Activities	-23.59	-33.85	-20.32	12.11	-28.44
Net Cash flow from Financing Activities	-0.52	-3.22	-3.63	-5.01	-15.07
Net Cash Flow	31.79	6.68	2.94	30.31	-6.19
Closing Cash & Cash Equivalent	100.62	68.83	62.15	59.21	28.89
Closing Cash & Cash Equivalent Growth (%)	46.18	10.76	4.97	104.92	-17.64
Total Debt/ CFO (x)	0.06	0.01	0.03	0.09	0.07

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	42.82	44.47	28.47	1.65	7.98
Net Cash used in Investing Activities	-19.80	-33.64	-20.32	-0.02	-1.52
Net Cash flow from Financing Activities	-6.55	-3.07	-3.62	-2.57	-6.31
Net Cash Flow	16.47	7.76	4.53	-0.95	0.14
Closing Cash & Cash Equivalent	79.10	62.63	54.88	0.90	1.85
Closing Cash & Cash Equivalent Growth (%)	26.29	14.13	5,968.61	-51.18	8.40
Total Debt/ CFO (x)	0.00	0.01	0.03	1.23	0.32

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 23.59 cr for investing activities which is an YoY decrease of 30.29%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	18.06	17.76	14.39	15.14	21.04
Return on Capital Employed (%)	22.61	23.13	19.28	17.76	24.73
Return on Assets (%)	15.49	16.12	12.93	12.11	16.76
Interest Coverage Ratio (x)	347.25	600.85	365.87	183.32	413.58
Asset Turnover Ratio (x)	0.42	0.35	0.32	0.30	0.14
Price to Earnings (x)	16.47	29.07	20.58	12.02	7.94
Price to Book (x)	2.97	5.16	2.96	1.82	1.67
EV/EBITDA (x)	10.62	20.24	13.19	7.67	5.64
EBITDA Margin (%)	58.01	67.57	61.40	58.81	54.56

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	15.45	17.43	15.02	8.91	33.46
Return on Capital Employed (%)	20.38	22.95	19.99	10.94	33.37
Return on Assets (%)	14.07	16.00	13.69	7.23	25.33
Interest Coverage Ratio (x)	1,534.03	670.27	416.76	15.89	83.28
Asset Turnover Ratio (x)	0.30	0.33	0.51	0.39	0.51
Price to Earnings (x)	19.57	29.15	19.31	144.93	31.95
Price to Book (x)	3.02	5.08	2.89	12.86	10.68
EV/EBITDA (x)	13.15	20.39	12.76	99.11	28.93
EBITDA Margin (%)	69.23	71.66	67.05	26.28	57.07

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Kilpest India	17.20	3.04	18.06	22.61	15.49	33.95	54.40	42.22	69.94	5.27	0.01	0.06
Bhagiradha Chem	201.57	5.25	2.60	4.40	1.62	2.24	7.19	3.39	1.40	1.78	0.33	19.23
Bharat Rasayan	15.34	1.75	11.43	16.50	10.17	0.77	17.23	11.50	87.67	7.78	0.00	0.01
Insecticide Ind	13.59	1.55	11.42	16.13	6.96	6.02	9.49	6.50	47.91	1.96	0.12	1.44
India Pesticides	12.00	1.84	11.86	16.18	8.96	6.22	16.38	11.33	10.40	3.19	0.11	1.74
Add More

Annual Ratios (%)

Choose from Peers

Astec Lifesc
Punjab Chemical
Excel Ind
Heranba Ind
Advance Agrolife Ltd.

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Kilpest India Stock Performance	1.22	-14.36	-15.44	0.00	0.00	0.00	0.00
Bhagiradha Chem Stock Performance	0.21	13.77	13.21	37.55	-5.58	82.34	0.00
Bharat Rasayan Stock Performance	-1.71	-4.01	-10.63	-15.48	-45.17	-45.88	-56.56
Insecticide Ind Stock Performance	-1.11	-8.11	-9.05	5.08	-13.10	43.03	74.61
India Pesticides Stock Performance	-1.36	-4.60	3.82	4.73	-6.11	-26.36	0.00
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	35,13,768	40.94 %	-0.34
Pledge	0	0.00 %	0.00
FII	2,20,396	2.57 %	0.00
DII	1,70,004	1.98 %	0.10
MF	215	0.00 %	0.00
Others	46,78,502	54.51 %	0.23

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	40.94	41.28	41.28	41.28
Pledge	0.00	0.00	0.00	0.00
FII	2.57	2.57	2.64	2.70
DII	1.98	1.87	1.82	1.76
Mutual Funds	0.00	0.00	0.00	0.00
Others	54.51	54.28	54.26	54.26

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- -8.78
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- 7.81
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Final
50%
May 29, 2026
Board Meeting
Audited Results & Final Dividend
May 20, 2026
Board Meeting
Quarterly Results
Jan 30, 2026

Board Meetings

Announced on	Meeting on
May 20, 2026	May 29, 2026
Audited Results & Final Dividend
Jan 30, 2026	Feb 06, 2026
Quarterly Results
Nov 06, 2025	Nov 13, 2025
Quarterly Results
Aug 06, 2025	Aug 14, 2025
Quarterly Results
May 19, 2025	May 28, 2025
Audited Results & Dividend

Dividends
Announced on Ex-Date Dividend%
May 28, 2025 Sep 19, 2025 40%
May 30, 2024 Sep 17, 2024 30%
Aug 30, 2023 Sep 15, 2023 25%
May 27, 2022 Sep 14, 2022 25%
May 29, 2026 - 50%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
May 28, 2025	Sep 19, 2025	40%
May 30, 2024	Sep 17, 2024	30%
Aug 30, 2023	Sep 15, 2023	25%
May 27, 2022	Sep 14, 2022	25%
May 29, 2026	-	50%

AGM/EGM Meetings

Announced on	Meeting on
Sep 04, 2025	Sep 26, 2025
-
Sep 04, 2024	Sep 24, 2024
Rs.3.0000 per share(30%)Final Dividend & A.G.M.
Aug 30, 2023	Sep 22, 2023
Rs.2.5000 per share(25%)Final Dividend & A.G.M.
Sep 01, 2020	Sep 25, 2020
Book closure from Sep 19, 2020 to Sep 25, 2020
Sep 04, 2019	-
Book closure from Sep 19, 2019 to Sep 25, 2019

About Kilpest India

3B BlackBio Dx Ltd., incorporated in the year 1972, is a Small Cap company (having a market cap of Rs 1,007.43 Crore) operating in Pesticides/Agro Chemicals sector.

3B BlackBio Dx Ltd. key Products/Revenue Segments include Agrochemicals for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 45.58 Crore, down 18.51 % from last quarter Total Income of Rs 55.93 Crore and up 66.13 % from last year same quarter Total Income of Rs 27.44 Crore. Company has reported net profit after tax of Rs 9.80 Crore in latest quarter.

The company’s top management includes Mr.Dhirendra Dubey, Mr.N K Dubey, Mr.Abdul Moin Khan, Mr.Harihar Prasad Thapak, Mrs.Mithala Dubey, Mr.Vivek Saihgal, Mrs.Navneet Kaur. Company has Baheti & Co. as its auditors. As on 31-03-2026, the company has a total of .86 Crore shares outstanding.

Kilpest India Share Price Today is Rs. 1173.80. On previous day, the Kilpest India Share Price (NSE) closed at Rs. 1170.5, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 40.94% of the stake in Kilpest India shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Kilpest India stocks was 2.57% as compared to 2.57% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 1.98% as compared to 1.87% in Dec 2025 with increase of 0.11%. Out of the total DII holdings in Kilpest India shares 0.0% was held by mutual funds. The rest including public held is 54.51%. Kilpest India stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Kilpest India Dividend: Ever since 1972, Kilpest India dividends has been paid out around 15 times. As on 29 Jun, 2026, 03:46 PM IST, The overall dividend yield for Kilpest India stands at 0.43%. The last dividend paid was on September 19, 2025 (Rs. 4.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 68.26.

Kilpest India Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 45.58 Cr. of sales and 18.51% of quarterly net loss, there have been multiple ups and downs in the Kilpest India stock prices in the past few weeks. For example, Kilpest India stock price on 19th of June 2026 was around Rs. 1201.1. Kilpest India share price now stands at an average of Rs. 1173.80. Judging by last week's performance, stock is in down trend.

Kilpest India has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Kilpest India share.

Historical Prices and Performance:
Kilpest India, incorporated in 1972 is a Small Cap company (with a market cap of Rs. 995.33) operating in Pesticides/Agro Chemicals sector.
The Return of Equity (ROE) in last five financial years given by Kilpest India stock was 18.06%, 17.76%, 14.39%, 15.14% and 21.04% respectively.
The Kilpest India share gave a 3 year return of 200.88% as compared to Nifty 50 which gave a return of 38.24%.
Kilpest India announced 40.0% final dividend on September 19, 2025.

Key Metrics:
PE Ratio of Kilpest India is 16.99
Prices/Sales Ratio of Kilpest India is 6.8
Price/Book Ratio of Kilpest India is 3.0

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Kilpest India, major competitors and peers include Bhagiradha Chem, Bharat Rasayan, Insecticide Ind and India Pesticides. As of Dec 2025, the dividend yield of Kilpest India stands at 0.43% while Bhagiradha Chem, Bharat Rasayan, Insecticide Ind and India Pesticides stand at 0.05%, 0.0%, 0.3% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 16.99 and 3.0 respectively.

Leadership of Kilpest India :
Navneet Kaur is Co. Secretary & Compl. Officer
Dhirendra Dubey is Chairman & Managing Director
N K Dubey is Whole Time Director
Harihar Prasad Thapak is Independent Director
Abdul Moin Khan is Independent Director
Mithala Dubey is Director
Vivek Saihgal is Additional Director

Industry

Pesticides/Agro Chem

Key Indices Listed On

BSE Healthcare, BSE AllCap

Address

7-C, Industrial Area,Govindpura,Bhopal, Madhya Pradesh - 462023

Contact

info@kilpest.com

http://www.kilpest.com

PE Ratio(x)	17.20
EPS - TTM(₹)	68.26
MCap(₹ Cr.)	1,007.43
MCap Rank	19
PB Ratio(x)	3.00
Div Yield(%)	0.43
Face Value(₹)	10.00
52W High(₹)	1,441.50
52W Low(₹)	1,085.00
MCap/Sales	6.80
Beta(1 Month)	-
BV/Share(₹)	386.41

PE Ratio(x)	17.14
EPS - TTM(₹)	68.26
MCap(₹ Cr.)	1,004.17
MCap Rank	19
PB Ratio(x)	2.99
Div Yield(%)	0.43
Face Value(₹)	10.00
52W High(₹)	1,750.00
52W Low(₹)	1,083.50
MCap/Sales	6.80
Beta(1 Month)	0.57
BV/Share(₹)	386.41

1 Day	1.22%
1 Month	-5.43%
3 Months	N.A.
1 Year	N.A.
3 Years	N.A.
5 Years	N.A.

1 Day	0.67%
1 Month	-5.95%
3 Months	0.21%
1 Year	-18.04%
3 Years	186.34%
5 Years	73.85%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Kilpest India - 3B BlackBio Dx Share Price

Key Metrics

Kilpest India share price insights

Kilpest India Share Price Returns

Kilpest India Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Motilal Oswal BSE Healthcare ETF-G

Bandhan BSE Healthcare Index Direct-G

Kilpest India Top Searches

Corporate Actions

About Kilpest India

Executive Leadership

Auditors

FAQs about Kilpest India share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News